Spero Therapeutics (SPRO) Short term Debt (2016 - 2022)
Spero Therapeutics posted quarterly Short term Debt of $141000.0 for Q3 2022, up 22.61% on a QoQ basis from $115000.0 in Q2 2022.
Spero Therapeutics (SPRO) has 5 years of Short term Debt data on file, last reported at $141000.0 in Q3 2022.
- For the quarter ending Q3 2022, Short term Debt changed N/A year-over-year to $141000.0; the trailing twelve-month figure through Sep 2022 stood at $141000.0 (changed N/A YoY), and the FY2018 full-year result was $223000.0, changed 0.0% from the prior year.
- Short term Debt for Q3 2022 stood at $141000.0, up from $115000.0 in the prior quarter.
- Across five years, Short term Debt topped out at $995000.0 in Q1 2022 and bottomed at $115000.0 in Q2 2022.
- The 3-year median for Short term Debt is $223000.0 (2018), against an average of $281200.0.
- Peak annual rise in Short term Debt reached 2.76% in 2018, while the deepest fall reached 0.0% in 2018.
- A 3-year view of Short term Debt shows it stood at $223000.0 in 2018, then changed by 0.0% to $223000.0 in 2019, then sank by 36.77% to $141000.0 in 2022.
- The last three Short term Debt figures came in at $141000.0 (Q3 2022), $115000.0 (Q2 2022), and $995000.0 (Q1 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 141,000.00 |
| Jun 30, 2022 | 115,000.00 |
| Mar 31, 2022 | 995,000.00 |
| Sep 30, 2019 | 223,000.00 |
| Jun 30, 2019 | 223,000.00 |
| Mar 31, 2019 | 223,000.00 |
| Dec 31, 2018 | 223,000.00 |
| Sep 30, 2018 | 223,000.00 |
| Jun 30, 2018 | 223,000.00 |
| Mar 31, 2018 | 223,000.00 |
| Dec 31, 2017 | 223,000.00 |
| Sep 30, 2017 | 217,000.00 |
| Dec 31, 2016 | 2.71 Mn |